It's no secret that developing a new drug or medical device is an expensive and time-consuming endeavor. Often, despite the best efforts of those involved, traditional clinical trials end up wasting ...
NATIONAL — [March 31, 2026] — The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards), an initiative dedicated to improving participation in and access to clinical trials, is ...
NORTHAMPTON, MA / ACCESS Newswire / February 11, 2026 / The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards), along with the American Heart Association (Heart Association), and ...
STATEN ISLAND, N.Y., March 9, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for ...
Qualcomm Life announced two major partnerships at CES15 this year: one with pharmaceutical company Novartis and the other with pharmacy chain Walgreens. Novartis selected Qualcomm Life as a partner ...
Clinical trials are frightening endeavors for biotech investors. Expensive and fraught with risk, a trial’s failure can seriously lighten an investor’s pockets with little hope of recourse. After ...
Medical product sponsors can apply for a pilot program launched by the UK’s Medicines and Healthcare Regulatory products Agency (MHRA) that allows them to make certain changes to their clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results